| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 4.25e-05 | 9 | 162 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.27e-05 | 125 | 162 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 8.25e-05 | 11 | 162 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.36e-04 | 151 | 162 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | ubiquitin activating enzyme activity | 3.88e-04 | 4 | 162 | 2 | GO:0004839 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 3.91e-04 | 18 | 162 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.62e-04 | 19 | 162 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.01e-04 | 171 | 162 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.21e-04 | 22 | 162 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 8.24e-04 | 23 | 162 | 3 | GO:0015377 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.71e-05 | 9 | 162 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.56e-04 | 14 | 162 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRE GABRG1 SEMA4B ADGRB3 NBEA DCC SLC12A5 NRP1 SORCS3 LRRC7 GABRA6 | 3.30e-04 | 405 | 162 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 4.04e-04 | 19 | 162 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 5.48e-04 | 21 | 162 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRE GABRG1 SEMA4B ADGRB3 NBEA DCC CNTN6 SLC12A5 NRP1 SORCS3 LRRC7 EPB41L1 GABRA6 | 6.34e-04 | 583 | 162 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.10e-04 | 96 | 162 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | dendrite membrane | 9.33e-04 | 56 | 162 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 9.94e-04 | 201 | 162 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.30e-03 | 28 | 162 | 3 | GO:0097346 | |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | PF09430 | |
| Domain | DUF2012 | 2.45e-06 | 4 | 160 | 3 | IPR019008 | |
| Domain | FN3 | SDK2 EPHA6 KALRN AXL KIAA0319L DCC DSCAML1 CNTN6 KIAA0319 HCFC1 | 4.49e-06 | 185 | 160 | 10 | SM00060 |
| Domain | Ig-like_fold | SEMA4B SDK2 EPHA6 KALRN PSG2 AXL LAG3 DCC DSCAML1 CNTN6 NOMO1 KIAA0319 TGM4 F11R NOMO2 FCGRT CEACAM20 HCFC1 NOMO3 | 1.02e-05 | 706 | 160 | 19 | IPR013783 |
| Domain | FN3_dom | SDK2 EPHA6 KALRN AXL KIAA0319L DCC DSCAML1 CNTN6 KIAA0319 HCFC1 | 1.31e-05 | 209 | 160 | 10 | IPR003961 |
| Domain | SLC12_C | 3.35e-05 | 8 | 160 | 3 | IPR018491 | |
| Domain | Carb-bd-like_fold | 3.35e-05 | 8 | 160 | 3 | IPR013784 | |
| Domain | SLC12 | 3.35e-05 | 8 | 160 | 3 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 3.36e-05 | 22 | 160 | 4 | IPR004841 | |
| Domain | AA_permease | 3.36e-05 | 22 | 160 | 4 | PF00324 | |
| Domain | Ig_I-set | 3.89e-05 | 190 | 160 | 9 | IPR013098 | |
| Domain | I-set | 3.89e-05 | 190 | 160 | 9 | PF07679 | |
| Domain | - | SDK2 EPHA6 KALRN PSG2 AXL LAG3 DCC DSCAML1 CNTN6 NOMO1 TGM4 F11R NOMO2 FCGRT CEACAM20 HCFC1 NOMO3 | 5.62e-05 | 663 | 160 | 17 | 2.60.40.10 |
| Domain | DUF1088 | 7.29e-05 | 2 | 160 | 2 | IPR010508 | |
| Domain | DUF1088 | 7.29e-05 | 2 | 160 | 2 | PF06469 | |
| Domain | PKD | 9.68e-05 | 11 | 160 | 3 | PS50093 | |
| Domain | PKD_dom | 9.68e-05 | 11 | 160 | 3 | IPR000601 | |
| Domain | - | 9.68e-05 | 11 | 160 | 3 | 2.60.40.670 | |
| Domain | CarboxyPept_regulatory_dom | 1.66e-04 | 13 | 160 | 3 | IPR014766 | |
| Domain | - | 1.66e-04 | 13 | 160 | 3 | 2.60.40.1120 | |
| Domain | E1_4HB | 2.18e-04 | 3 | 160 | 2 | PF16191 | |
| Domain | E1_FCCH | 2.18e-04 | 3 | 160 | 2 | PF16190 | |
| Domain | GPCR_2_brain_angio_inhib | 2.18e-04 | 3 | 160 | 2 | IPR008077 | |
| Domain | UBQ-activ_enz_E1 | 2.18e-04 | 3 | 160 | 2 | IPR018075 | |
| Domain | UBA_e1_C | 2.18e-04 | 3 | 160 | 2 | SM00985 | |
| Domain | Ub-activating_enz_E1_C | 2.18e-04 | 3 | 160 | 2 | IPR018965 | |
| Domain | E1_4HB | 2.18e-04 | 3 | 160 | 2 | IPR032420 | |
| Domain | E1_FCCH | 2.18e-04 | 3 | 160 | 2 | IPR032418 | |
| Domain | E1_UFD | 2.18e-04 | 3 | 160 | 2 | PF09358 | |
| Domain | FN3 | 3.23e-04 | 199 | 160 | 8 | PS50853 | |
| Domain | CarboxyPept-like_regulatory | 3.84e-04 | 17 | 160 | 3 | IPR008969 | |
| Domain | SHR-BD | 4.33e-04 | 4 | 160 | 2 | IPR009543 | |
| Domain | DDT | 4.33e-04 | 4 | 160 | 2 | PF02791 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 1.10.3240.10 | |
| Domain | VPS13_C | 4.33e-04 | 4 | 160 | 2 | PF16909 | |
| Domain | VPS13_C | 4.33e-04 | 4 | 160 | 2 | IPR031645 | |
| Domain | KCL_cotranspt | 4.33e-04 | 4 | 160 | 2 | IPR000076 | |
| Domain | SHR-BD | 4.33e-04 | 4 | 160 | 2 | PF06650 | |
| Domain | fn3 | 4.99e-04 | 162 | 160 | 7 | PF00041 | |
| Domain | DDT | 7.17e-04 | 5 | 160 | 2 | SM00571 | |
| Domain | UBIQUITIN_ACTIVAT_1 | 7.17e-04 | 5 | 160 | 2 | PS00536 | |
| Domain | UBA_E1_Cys | 7.17e-04 | 5 | 160 | 2 | IPR019572 | |
| Domain | DDT_dom | 7.17e-04 | 5 | 160 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 7.17e-04 | 5 | 160 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 7.17e-04 | 5 | 160 | 2 | IPR028941 | |
| Domain | WSD | 7.17e-04 | 5 | 160 | 2 | PF15613 | |
| Domain | WHIM1 | 7.17e-04 | 5 | 160 | 2 | PF15612 | |
| Domain | UBIQUITIN_ACTIVAT_2 | 7.17e-04 | 5 | 160 | 2 | PS00865 | |
| Domain | DUF4704 | 7.17e-04 | 5 | 160 | 2 | IPR031570 | |
| Domain | UBA_e1_thiolCys | 7.17e-04 | 5 | 160 | 2 | PF10585 | |
| Domain | DUF4704 | 7.17e-04 | 5 | 160 | 2 | PF15787 | |
| Domain | CT | 8.43e-04 | 22 | 160 | 3 | SM00041 | |
| Domain | GABAA/Glycine_rcpt | 9.63e-04 | 23 | 160 | 3 | IPR006028 | |
| Domain | IGc2 | 9.66e-04 | 235 | 160 | 8 | SM00408 | |
| Domain | Ig_sub2 | 9.66e-04 | 235 | 160 | 8 | IPR003598 | |
| Domain | DDT | 1.07e-03 | 6 | 160 | 2 | PS50827 | |
| Domain | PH_BEACH | 1.07e-03 | 6 | 160 | 2 | PF14844 | |
| Domain | MANSC | 1.07e-03 | 6 | 160 | 2 | PS50986 | |
| Domain | UBQ/SUMO-activ_enz_E1-like | 1.07e-03 | 6 | 160 | 2 | IPR000011 | |
| Domain | MANSC_dom | 1.07e-03 | 6 | 160 | 2 | IPR013980 | |
| Domain | PKD/REJ-like | 1.07e-03 | 6 | 160 | 2 | IPR002859 | |
| Domain | REJ | 1.07e-03 | 6 | 160 | 2 | PF02010 | |
| Domain | Cys_knot_C | 1.24e-03 | 25 | 160 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.24e-03 | 25 | 160 | 3 | PS01225 | |
| Domain | ig | 1.27e-03 | 190 | 160 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.27e-03 | 190 | 160 | 7 | IPR013151 | |
| Domain | TAAR_fam | 1.49e-03 | 7 | 160 | 2 | IPR009132 | |
| Domain | SLC12A_fam | 1.49e-03 | 7 | 160 | 2 | IPR004842 | |
| Domain | Transciption_factor_Maf_fam | 1.49e-03 | 7 | 160 | 2 | IPR024874 | |
| Domain | Chorein_N | 1.97e-03 | 8 | 160 | 2 | PF12624 | |
| Domain | PH-BEACH_dom | 1.97e-03 | 8 | 160 | 2 | IPR023362 | |
| Domain | VPS13_N | 1.97e-03 | 8 | 160 | 2 | IPR026854 | |
| Domain | - | 1.97e-03 | 8 | 160 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.97e-03 | 8 | 160 | 2 | PS51783 | |
| Domain | BEACH | 2.52e-03 | 9 | 160 | 2 | PS50197 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | PF02138 | |
| Domain | - | 2.52e-03 | 9 | 160 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.52e-03 | 9 | 160 | 2 | IPR000409 | |
| Domain | PKD/Chitinase_dom | 2.52e-03 | 9 | 160 | 2 | IPR022409 | |
| Domain | PKD | 2.52e-03 | 9 | 160 | 2 | SM00089 | |
| Domain | ThiF_NAD_FAD-bd | 3.14e-03 | 10 | 160 | 2 | IPR000594 | |
| Domain | ThiF | 3.14e-03 | 10 | 160 | 2 | PF00899 | |
| Domain | IG_LIKE | SDK2 KALRN PSG2 AXL LAG3 DCC DSCAML1 CNTN6 F11R FCGRT CEACAM20 | 3.43e-03 | 491 | 160 | 11 | PS50835 |
| Domain | IG | 3.46e-03 | 421 | 160 | 10 | SM00409 | |
| Domain | Ig_sub | 3.46e-03 | 421 | 160 | 10 | IPR003599 | |
| Domain | GAIN_dom_N | 3.81e-03 | 11 | 160 | 2 | IPR032471 | |
| Domain | GAIN | 3.81e-03 | 11 | 160 | 2 | PF16489 | |
| Domain | Ig-like_dom | SDK2 KALRN PSG2 AXL LAG3 DCC DSCAML1 CNTN6 F11R FCGRT CEACAM20 | 4.11e-03 | 503 | 160 | 11 | IPR007110 |
| Domain | C8 | 4.55e-03 | 12 | 160 | 2 | PF08742 | |
| Domain | TIL | 4.55e-03 | 12 | 160 | 2 | PF01826 | |
| Domain | bZIP_Maf | 5.35e-03 | 13 | 160 | 2 | IPR004826 | |
| Domain | Unchr_dom_Cys-rich | 5.35e-03 | 13 | 160 | 2 | IPR014853 | |
| Domain | C8 | 5.35e-03 | 13 | 160 | 2 | SM00832 | |
| Domain | bZIP_Maf | 5.35e-03 | 13 | 160 | 2 | PF03131 | |
| Domain | TIL_dom | 6.20e-03 | 14 | 160 | 2 | IPR002919 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.73e-03 | 45 | 160 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 7.15e-03 | 46 | 160 | 3 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 7.59e-03 | 47 | 160 | 3 | IPR006029 | |
| Domain | - | 7.59e-03 | 47 | 160 | 3 | 2.70.170.10 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | EP400 MED16 RBBP5 POGZ GRHL2 EMSY KANSL3 BPTF SALL2 MGA HCFC1 ZMYM4 | 3.02e-11 | 167 | 165 | 12 | 20362541 |
| Pubmed | EP400 AHCTF1 SPAG9 POGZ SPECC1L EMSY TAB3 BPTF NCOR1 FASN UBA1 ALMS1 NFRKB LRBA MGA CNOT1 HCFC1 ZMYM4 | 1.62e-10 | 549 | 165 | 18 | 38280479 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.23e-09 | 146 | 165 | 10 | 23892456 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SDSL SEMA4B EP400 KALRN KIAA0319L MTMR8 ADGRB2 PSMB10 BTAF1 BCR C2CD2L KANSL3 SCAF1 NCOR1 SLC7A1 FASN ANKRD34A CEP131 MAFF LRBA MBD5 HCFC1 CBX2 | 3.00e-09 | 1105 | 165 | 23 | 35748872 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 RBBP5 LIN54 FRMPD1 SPAG9 BTAF1 POGZ EMSY MRPS18A KANSL3 BPTF NCOR1 FASN PRDM10 SALL2 BAZ1A EIF5B MGA HCFC1 ZMYM4 | 5.29e-09 | 857 | 165 | 20 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CYP2C18 EP400 SPAG9 BTAF1 POGZ EMSY PAPOLG KANSL3 BPTF SCAF1 NCOR1 FASN UBA1 NFRKB EIF5B YY1AP1 NMT1 ZMYM4 WDR62 | 5.84e-09 | 774 | 165 | 19 | 15302935 |
| Pubmed | EP400 MED16 RBBP5 LIN54 GRHL2 EMSY ZNF512B KANSL3 NCOR1 NFRKB MGA HCFC1 | 6.81e-09 | 268 | 165 | 12 | 33640491 | |
| Pubmed | HECW1 KALRN ADGRB2 ADGRB3 TPPP NBEA SPECC1L BCR EMSY SLC12A5 KIAA0319 NCOR1 UBA1 DCHS1 UBA6 CEP131 LRRC7 MGA CNOT1 CNP EPB41L1 | 6.95e-09 | 963 | 165 | 21 | 28671696 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | EP400 RBBP5 LIN54 POGZ EMSY ZNF512B BPTF NCOR1 ALMS1 BAZ1A NFRKB MGA ZMYM4 | 1.51e-08 | 351 | 165 | 13 | 38297188 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 LIN54 BCR EMSY PAPOLG KANSL3 PPP4R3B NCOR1 GPBP1L1 SALL2 ALMS1 NOMO2 MTR YY1AP1 CEP131 ZMYM4 | 2.43e-08 | 588 | 165 | 16 | 38580884 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EP400 LIN54 SRP54 SPAG9 EMSY PAPOLG KANSL3 NCOR1 UBA1 SALL2 NFRKB MGA HCFC1 ZMYM4 | 3.12e-08 | 444 | 165 | 14 | 34795231 |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.05e-07 | 3 | 165 | 3 | 25576386 | |
| Pubmed | LIN54 POGZ BCR NCOR1 FASN SALL2 ALMS1 CEP131 LRBA MGA CNOT1 ZMYM4 WDR62 | 1.16e-07 | 418 | 165 | 13 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RBBP5 AHCTF1 LIN54 BTAF1 POGZ EMSY PAPOLG ZNF512B BPTF BAZ1A NFRKB MGA HCFC1 ZMYM4 CBX2 | 2.39e-07 | 608 | 165 | 15 | 36089195 |
| Pubmed | EP400 RBBP5 LIN54 SPAG9 POGZ EMSY TAB3 MRPS18A ZNF512B KANSL3 BPTF NCOR1 SALL2 ALMS1 NFRKB MTR YY1AP1 CEP131 MGA CNOT1 HCFC1 ZMYM4 CBX2 | 3.19e-07 | 1429 | 165 | 23 | 35140242 | |
| Pubmed | MAFG EP400 MED16 LIN54 SRP54 POGZ EMSY CCDC7 KANSL3 PPP4R3B BPTF NCOR1 FASN UBA1 NFRKB EIF5B CNOT1 COPS5 HCFC1 ZMYM4 | 3.20e-07 | 1103 | 165 | 20 | 34189442 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.18e-07 | 4 | 165 | 3 | 31833031 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 9267806 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GABRE EPHA6 WDR4 FRMPD1 SRP54 BTAF1 BCR GRHL2 NRP1 KANSL3 BPTF SLC7A1 THRA UBA6 RASEF LRRC7 LRBA MBD5 CNOT1 COPS5 VPS13B ZMYM4 EPB41L1 | 6.50e-07 | 1489 | 165 | 23 | 28611215 |
| Pubmed | 6.87e-07 | 104 | 165 | 7 | 9205841 | ||
| Pubmed | EP400 LIN54 MUC19 POGZ EMSY SALL2 NOMO2 NFRKB YY1AP1 MGA HCFC1 | 7.43e-07 | 339 | 165 | 11 | 30415952 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | RC3H2 RBBP5 LIN54 POGZ ZNF512B KANSL3 BPTF NFRKB MBD5 MGA HCFC1 ZMYM4 CBX2 | 7.85e-07 | 495 | 165 | 13 | 27705803 |
| Pubmed | 1.15e-06 | 162 | 165 | 8 | 25826454 | ||
| Pubmed | SDK2 EP400 ADGRB3 KIAA1549 POGZ BCR ZNF512B FMNL3 KANSL3 PPP4R3B SLIT3 CNOT1 ZMYM4 | 1.64e-06 | 529 | 165 | 13 | 14621295 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EP400 BTAF1 SPECC1L NRP1 ZNF512B BPTF SCAF1 FASN UBA1 F11R BAZ1A GLE1 UBA6 EIF5B CEP131 MGA CNOT1 CNP | 2.01e-06 | 1024 | 165 | 18 | 24711643 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.13e-06 | 123 | 165 | 7 | 26912792 | |
| Pubmed | 2.25e-06 | 124 | 165 | 7 | 20850016 | ||
| Pubmed | EP400 CAMLG BCR C2CD2L PAPOLG ALMS1 NOMO2 GLE1 GUSB NFRKB MTR CEP131 MGA HCFC1 WDR62 | 2.45e-06 | 733 | 165 | 15 | 34672954 | |
| Pubmed | 3.08e-06 | 130 | 165 | 7 | 12421765 | ||
| Pubmed | 3.46e-06 | 251 | 165 | 9 | 27507650 | ||
| Pubmed | SCFD2 CAMLG AHCTF1 POR SRP54 SPAG9 C2CD2L FASN VPS13D LRBA SLC12A7 HCFC1 VPS13B | 3.56e-06 | 568 | 165 | 13 | 37774976 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 19131338 | ||
| Pubmed | EP400 FRMPD1 POGZ SLC12A5 RUSC2 C2CD2L KIAA0319 YY1AP1 LRRC7 VPS13B EPB41L1 | 4.33e-06 | 407 | 165 | 11 | 12693553 | |
| Pubmed | 5.06e-06 | 263 | 165 | 9 | 34702444 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 5.77e-06 | 8 | 165 | 3 | 15257293 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.87e-06 | 341 | 165 | 10 | 32971831 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HGD COL15A1 KALRN AHCTF1 SPAG9 CPNE5 BCR F11 RUSC2 TGM4 FASN VPS13D UBA1 SLC12A9 GUSB MBD5 CNP | 7.49e-06 | 1016 | 165 | 17 | 19056867 |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 19323993 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 8.63e-06 | 9 | 165 | 3 | 36261522 | |
| Pubmed | EP400 MED16 RBBP5 AHCTF1 SRP54 SPECC1L EMSY NOMO1 C2CD2L SCAF1 GPBP1L1 BAZ1A NFRKB EIF5B CRYBG1 CEP131 NMT1 FHIP1A ZMYM4 CNP EPB41L1 | 9.16e-06 | 1497 | 165 | 21 | 31527615 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 AHCTF1 SRP54 SPAG9 BTAF1 EMSY ZNF512B FASN UBA1 ALMS1 BAZ1A EIF5B LRBA NMT1 HCFC1 WDR62 | 1.05e-05 | 934 | 165 | 16 | 33916271 |
| Pubmed | 1.18e-05 | 222 | 165 | 8 | 37071664 | ||
| Pubmed | RC3H2 RBBP5 BTAF1 BCR NRP1 RUSC2 MTR YY1AP1 C4B SLC12A7 NMT1 HCFC1 EPB41L1 | 1.50e-05 | 650 | 165 | 13 | 38777146 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.68e-05 | 11 | 165 | 3 | 32820719 | |
| Pubmed | SEMA4B EPHA6 OR9I1 EMSY PAPOLG SCAF1 SLC7A1 FASN PRDM10 UBA1 THRA SLC12A9 MCM9 NFRKB RASEF MAFF MGA CNOT1 ZMYM4 | 1.91e-05 | 1327 | 165 | 19 | 32694731 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15131262 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25783894 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21836066 | ||
| Pubmed | NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. | 2.24e-05 | 2 | 165 | 2 | 29273766 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25048447 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12218411 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24473438 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22972916 | ||
| Pubmed | Identification and characteristics of a novel E1 like gene nUBE1L in human testis. | 2.24e-05 | 2 | 165 | 2 | 15202508 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27188183 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22999844 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 2.24e-05 | 2 | 165 | 2 | 35575905 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 2.24e-05 | 2 | 165 | 2 | 29749459 | |
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 2.24e-05 | 2 | 165 | 2 | 31837806 | |
| Pubmed | Multiple mechanisms regulate H3 acetylation of enhancers in response to thyroid hormone. | 2.24e-05 | 2 | 165 | 2 | 32453730 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28978553 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32283037 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32315024 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 2.24e-05 | 2 | 165 | 2 | 27821723 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35008006 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24030394 | ||
| Pubmed | Differences in the large extracellular loop between the K(+)-Cl(-) cotransporters KCC2 and KCC4. | 2.24e-05 | 2 | 165 | 2 | 20516068 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 36766785 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37945738 | ||
| Pubmed | Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. | 2.24e-05 | 2 | 165 | 2 | 12106695 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22514273 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23610395 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 38741428 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30764693 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29145717 | ||
| Pubmed | Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. | 2.24e-05 | 2 | 165 | 2 | 9288753 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26419929 | ||
| Pubmed | A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant. | 2.24e-05 | 2 | 165 | 2 | 24381310 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17519354 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32831639 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24118457 | ||
| Pubmed | CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | 2.24e-05 | 2 | 165 | 2 | 38940054 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26754066 | ||
| Pubmed | CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux. | 2.24e-05 | 2 | 165 | 2 | 33352225 | |
| Pubmed | 2.32e-05 | 177 | 165 | 7 | 26206133 | ||
| Pubmed | EP400 AHCTF1 KIAA1549 POGZ BCR C2CD2L ZNF512B BPTF SCAF1 SALL2 THRA ALMS1 NFRKB MTR TAF4B MGA WDR62 | 2.49e-05 | 1116 | 165 | 17 | 31753913 | |
| Pubmed | RC3H2 EP400 AUH AHCTF1 SRP54 POGZ SPECC1L NRP1 KANSL3 SCAF1 FASN BAZ1A C4B CEP131 NMT1 CNOT1 HCFC1 CNP CBX2 | 2.98e-05 | 1371 | 165 | 19 | 36244648 | |
| Pubmed | KALRN AHCTF1 PPP4R3B NCOR1 FASN UBA1 EIF5B CEP131 NMT1 HCFC1 EPB41L1 | 3.09e-05 | 503 | 165 | 11 | 16964243 | |
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 16452088 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SCFD2 MAFG AHCTF1 LIN54 SPAG9 POGZ KANSL3 FASN UBA1 CEP131 MAFF CNOT1 COPS5 HCFC1 VPS13B ZMYM4 WDR62 | 3.82e-05 | 1155 | 165 | 17 | 20360068 |
| Pubmed | 3.84e-05 | 79 | 165 | 5 | 18978678 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | CAMLG KIAA0319L POR SRP54 NOMO1 SLC7A1 FASN NOMO2 LRBA CNP NOMO3 | 3.90e-05 | 516 | 165 | 11 | 36610398 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 4.53e-05 | 134 | 165 | 6 | 25452129 | |
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 10409670 | ||
| Pubmed | 4.59e-05 | 197 | 165 | 7 | 36604605 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MAFG EP400 RBBP5 AHCTF1 LIN54 POGZ EMSY ZNF512B KANSL3 BPTF SCAF1 NCOR1 BAZ1A NFRKB MAFF MGA HCFC1 ZMYM4 | 4.65e-05 | 1294 | 165 | 18 | 30804502 |
| Pubmed | 4.87e-05 | 83 | 165 | 5 | 28794006 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EP400 AHCTF1 LIN54 POGZ EMSY ZNF512B BPTF NCOR1 BAZ1A NFRKB EIF5B MGA HCFC1 ZMYM4 CBX2 | 5.35e-05 | 954 | 165 | 15 | 36373674 |
| Interaction | ELF4 interactions | 2.90e-08 | 115 | 161 | 10 | int:ELF4 | |
| Interaction | HNF4A interactions | EP400 MED16 RBBP5 LIN54 MUC19 POGZ EMSY KANSL3 BPTF NCOR1 NFRKB MGA COPS5 ZMYM4 | 4.70e-08 | 275 | 161 | 14 | int:HNF4A |
| Interaction | ELF1 interactions | 6.96e-08 | 126 | 161 | 10 | int:ELF1 | |
| Interaction | TFCP2L1 interactions | 9.92e-08 | 99 | 161 | 9 | int:TFCP2L1 | |
| Interaction | ELF2 interactions | 5.16e-07 | 156 | 161 | 10 | int:ELF2 | |
| Interaction | FEV interactions | EP400 LIN54 POGZ EMSY ZNF512B NCOR1 NFRKB YY1AP1 MGA ZMYM4 CBX2 | 7.37e-07 | 203 | 161 | 11 | int:FEV |
| Interaction | ASF1A interactions | EP400 LIN54 POGZ EMSY ZNF512B NCOR1 FASN SALL2 NFRKB MGA HCFC1 CBX2 | 7.95e-07 | 249 | 161 | 12 | int:ASF1A |
| Interaction | NFYC interactions | 1.64e-06 | 177 | 161 | 10 | int:NFYC | |
| Interaction | NFIX interactions | EP400 RBBP5 LIN54 POGZ EMSY KANSL3 BPTF NCOR1 NFRKB MGA ZMYM4 | 2.20e-06 | 227 | 161 | 11 | int:NFIX |
| Interaction | NUP43 interactions | EP400 RBBP5 AHCTF1 LIN54 MUC19 POGZ EMSY KANSL3 BPTF SCAF1 NCOR1 SALL2 BAZ1A NFRKB MGA CNOT1 HCFC1 ZMYM4 | 2.74e-06 | 625 | 161 | 18 | int:NUP43 |
| Interaction | WWTR1 interactions | EP400 AHCTF1 SPAG9 POGZ SPECC1L EMSY TAB3 BPTF NCOR1 UBA1 ALMS1 LRBA CNOT1 HCFC1 | 7.75e-06 | 422 | 161 | 14 | int:WWTR1 |
| Interaction | PAX6 interactions | MAFG WDR4 EP400 RBBP5 LIN54 POGZ GRHL2 ZNF512B BPTF NCOR1 NFRKB MGA ZMYM4 | 8.02e-06 | 366 | 161 | 13 | int:PAX6 |
| Interaction | TERF2IP interactions | EP400 AHCTF1 LIN54 BTAF1 POGZ EMSY ZNF512B KANSL3 BPTF NCOR1 SALL2 NFRKB MGA HCFC1 ZMYM4 CBX2 | 9.37e-06 | 552 | 161 | 16 | int:TERF2IP |
| Interaction | EGR2 interactions | 9.78e-06 | 171 | 161 | 9 | int:EGR2 | |
| Interaction | KLF3 interactions | 1.54e-05 | 228 | 161 | 10 | int:KLF3 | |
| Interaction | HNF1B interactions | 2.27e-05 | 190 | 161 | 9 | int:HNF1B | |
| Interaction | NANOG interactions | EP400 RBBP5 AHCTF1 MUC16 POGZ GRHL2 EMSY BPTF NCOR1 SALL2 MGA CNOT1 HCFC1 CBX2 | 3.32e-05 | 481 | 161 | 14 | int:NANOG |
| Interaction | PRPS2 interactions | 3.76e-05 | 253 | 161 | 10 | int:PRPS2 | |
| Interaction | H2AZ1 interactions | RC3H2 EP400 RBBP5 POGZ USP37 EMSY BPTF FASN BAZ1A HCFC1 ZMYM4 CBX2 | 4.51e-05 | 371 | 161 | 12 | int:H2AZ1 |
| Interaction | ETS1 interactions | 5.37e-05 | 121 | 161 | 7 | int:ETS1 | |
| Interaction | YY1 interactions | EP400 RBBP5 LIN54 POGZ EMSY ZNF512B KANSL3 BPTF FASN NFRKB MGA HCFC1 ZMYM4 | 7.54e-05 | 454 | 161 | 13 | int:YY1 |
| Interaction | MYB interactions | 9.76e-05 | 133 | 161 | 7 | int:MYB | |
| Interaction | DUXA interactions | 1.04e-04 | 12 | 161 | 3 | int:DUXA | |
| Interaction | TOP3B interactions | SDSL SEMA4B RC3H2 EP400 KALRN KIAA0319L MTMR8 ADGRB2 PSMB10 BTAF1 BCR C2CD2L KANSL3 SCAF1 NCOR1 SLC7A1 FASN ANKRD34A CEP131 MAFF LRBA MBD5 NMT1 CNOT1 HCFC1 CBX2 | 1.05e-04 | 1470 | 161 | 26 | int:TOP3B |
| Interaction | H3-3A interactions | RBBP5 AHCTF1 LIN54 SPAG9 BTAF1 POGZ EMSY PAPOLG ZNF512B BPTF BAZ1A NFRKB MGA COPS5 HCFC1 ZMYM4 CBX2 | 1.07e-04 | 749 | 161 | 17 | int:H3-3A |
| Interaction | LHX2 interactions | 1.14e-04 | 183 | 161 | 8 | int:LHX2 | |
| Interaction | POLR1E interactions | RC3H2 LIN54 POGZ EMSY ZNF512B FASN SALL2 BAZ1A EIF5B MGA ZMYM4 | 1.21e-04 | 350 | 161 | 11 | int:POLR1E |
| Interaction | KLHL4 interactions | 1.34e-04 | 33 | 161 | 4 | int:KLHL4 | |
| Interaction | MGA interactions | 1.38e-04 | 240 | 161 | 9 | int:MGA | |
| Interaction | CDC16 interactions | 1.66e-04 | 246 | 161 | 9 | int:CDC16 | |
| Interaction | SNRNP40 interactions | RC3H2 EP400 AHCTF1 POGZ USP37 EMSY PAPOLG SCAF1 NCOR1 PRDM10 GPBP1L1 NFRKB MGA COPS5 CBX2 | 1.86e-04 | 637 | 161 | 15 | int:SNRNP40 |
| Interaction | OR51E1 interactions | 1.89e-04 | 3 | 161 | 2 | int:OR51E1 | |
| Interaction | RAB2A interactions | KIAA0319L KIAA1549 NBEA BLZF1 BCR NRP1 NCOR1 SLC7A1 FASN F11R BAZ1A SLC12A7 CNP EPB41L1 | 1.89e-04 | 567 | 161 | 14 | int:RAB2A |
| Interaction | MAX interactions | 1.93e-04 | 251 | 161 | 9 | int:MAX | |
| Cytoband | 6q23.2 | 9.89e-05 | 25 | 165 | 3 | 6q23.2 | |
| GeneFamily | Fibronectin type III domain containing | 5.53e-05 | 160 | 110 | 7 | 555 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 1.10e-04 | 3 | 110 | 2 | 912 | |
| GeneFamily | Immunoglobulin like domain containing | 1.78e-04 | 193 | 110 | 7 | 594 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.98e-04 | 19 | 110 | 3 | 563 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.54e-04 | 161 | 110 | 6 | 593 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| GeneFamily | Trace amine receptors | 1.28e-03 | 9 | 110 | 2 | 188 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.60e-03 | 10 | 110 | 2 | 100 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.42e-06 | 170 | 165 | 7 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 173 | 165 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 173 | 165 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-06 | 174 | 165 | 7 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-06 | 177 | 165 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.35e-06 | 182 | 165 | 7 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 185 | 165 | 7 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 186 | 165 | 7 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.40e-06 | 187 | 165 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 7.10e-06 | 190 | 165 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.34e-06 | 191 | 165 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.60e-06 | 192 | 165 | 7 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-06 | 192 | 165 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.60e-06 | 192 | 165 | 7 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-06 | 192 | 165 | 7 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.13e-06 | 194 | 165 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-06 | 194 | 165 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 8.98e-06 | 197 | 165 | 7 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 197 | 165 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.28e-06 | 198 | 165 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 1.51e-05 | 142 | 165 | 6 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 145 | 165 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.28e-05 | 171 | 165 | 6 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 4.43e-05 | 172 | 165 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 173 | 165 | 6 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-05 | 174 | 165 | 6 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.87e-05 | 175 | 165 | 6 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-05 | 176 | 165 | 6 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-05 | 177 | 165 | 6 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 180 | 165 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 5.88e-05 | 181 | 165 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 3dec003bad0f3716cf8163861a9d4302a7d6df8c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-05 | 183 | 165 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 6.24e-05 | 183 | 165 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 185 | 165 | 6 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 185 | 165 | 6 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 6.83e-05 | 186 | 165 | 6 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.04e-05 | 187 | 165 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.04e-05 | 187 | 165 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 188 | 165 | 6 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 189 | 165 | 6 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 165 | 6 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-05 | 191 | 165 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-05 | 192 | 165 | 6 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-05 | 192 | 165 | 6 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 8.14e-05 | 192 | 165 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 8.14e-05 | 192 | 165 | 6 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 8.14e-05 | 192 | 165 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 193 | 165 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 193 | 165 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 193 | 165 | 6 | 80380358f44c2f4781676ec0f1fa94d4c69080d6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 193 | 165 | 6 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.37e-05 | 193 | 165 | 6 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.37e-05 | 193 | 165 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 193 | 165 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 194 | 165 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.62e-05 | 194 | 165 | 6 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.62e-05 | 194 | 165 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 195 | 165 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-05 | 195 | 165 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-05 | 195 | 165 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.11e-05 | 196 | 165 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | TCGA-Prostate|World / Sample_Type by Project: Shred V9 | 9.52e-05 | 123 | 165 | 5 | 22b38555652b7a426a6277ed385361ae275310a3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-05 | 198 | 165 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 198 | 165 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 9.91e-05 | 199 | 165 | 6 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 9.91e-05 | 199 | 165 | 6 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 9.91e-05 | 199 | 165 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 165 | 6 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.28e-04 | 131 | 165 | 5 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 132 | 165 | 5 | fc79898eeb39c26505cf04df95c3dd75a6593295 | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | RC3H2 AXL KIAA0319L ADGRB2 BCR EMSY PAPOLG CLCN4 NMT1 VPS13B | 1.44e-06 | 193 | 164 | 10 | 5119_DN |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 5.20e-06 | 175 | 164 | 9 | 3873_DN | |
| Disease | skin disease (implicated_via_orthology) | 8.52e-05 | 3 | 158 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 2.82e-04 | 5 | 158 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | JT interval | 3.96e-04 | 248 | 158 | 7 | EFO_0007885 | |
| Disease | Uveoretinal Coloboma | 5.88e-04 | 7 | 158 | 2 | C4554007 | |
| Disease | Intellectual Disability | 7.14e-04 | 447 | 158 | 9 | C3714756 | |
| Disease | underweight body mass index status | 1.00e-03 | 9 | 158 | 2 | EFO_0005936 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.00e-03 | 9 | 158 | 2 | EFO_0600040 | |
| Disease | Congenital ocular coloboma (disorder) | 1.00e-03 | 9 | 158 | 2 | C0009363 | |
| Disease | neutrophil count | SCFD2 MYO1G TPST1 FAM78B LIN54 HLX POGZ MRPS18A THRA F11R MS4A3 GUSB ANKRD34A YY1AP1 LRBA SLC12A7 ZMYM4 | 1.23e-03 | 1382 | 158 | 17 | EFO_0004833 |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 1.25e-03 | 10 | 158 | 2 | cv:CN043592 | |
| Disease | multisite chronic pain | 1.73e-03 | 95 | 158 | 4 | EFO_0010100 | |
| Disease | urate measurement, bone density | PSG2 AHCTF1 LIN54 ADGRB3 SALL2 C1QTNF9 TAF4B SLC2A12 DNAH8 GABRA6 | 1.92e-03 | 619 | 158 | 10 | EFO_0003923, EFO_0004531 |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 2.49e-03 | 14 | 158 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 2.60e-03 | 51 | 158 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | chenodeoxycholate measurement | 2.86e-03 | 15 | 158 | 2 | EFO_0010471 | |
| Disease | focal segmental glomerulosclerosis | 3.25e-03 | 16 | 158 | 2 | EFO_0004236 | |
| Disease | gliosarcoma | 3.25e-03 | 16 | 158 | 2 | C0206726 | |
| Disease | pulse pressure measurement | RC3H2 COL15A1 LIN54 NBEA POGZ CPNE5 SVEP1 FMNL3 FASN SLIT3 SORCS3 MBD5 NMT1 CNOT1 HCFC1 GABRA6 | 3.35e-03 | 1392 | 158 | 16 | EFO_0005763 |
| Disease | caudal anterior cingulate cortex volume measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0010289 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.99e-03 | 194 | 158 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | serum urea measurement | 4.08e-03 | 195 | 158 | 5 | EFO_0009795 | |
| Disease | esophageal adenocarcinoma | 4.12e-03 | 18 | 158 | 2 | EFO_0000478 | |
| Disease | longevity | 4.38e-03 | 284 | 158 | 6 | EFO_0004300 | |
| Disease | loneliness measurement | 4.51e-03 | 124 | 158 | 4 | EFO_0007865 | |
| Disease | hypertension, white matter hyperintensity measurement | 4.52e-03 | 62 | 158 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | Malignant neoplasm of breast | KALRN CYP24A1 FRMPD1 MTMR8 EMSY CNTN6 NCOR1 FASN ANKRD34A MTR LRRC7 LRBA VPS13B | 5.27e-03 | 1074 | 158 | 13 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVKLESTRTTVRTGL | 41 | O60507 | |
| GTPAISTTTTVEIRK | 151 | Q9H6B1 | |
| PALVVAVSVGFTRTK | 1046 | O60241 | |
| LSVPSVSKRVVLGDS | 76 | P49069 | |
| VAVVIDPTRTISAGK | 166 | Q92905 | |
| AILPKGSARVTTSVK | 1066 | Q96L91 | |
| ASTAIKVTETRTGPL | 201 | Q76B58 | |
| KTIEFTLPTVTNTVG | 1351 | Q96M83 | |
| VVPTAATAVSLKVVA | 901 | P0C0L5 | |
| PTTSLISVAVTKIIA | 221 | P49419 | |
| PVVVSEATIVGVRKT | 396 | P11274 | |
| PALVVATSVGFTRTK | 991 | O60242 | |
| ARSTSVLVKVVGPQS | 426 | Q6UY09 | |
| VLVKVVGPQSSSLSS | 431 | Q6UY09 | |
| TVTLVGPTNKISRFS | 121 | Q5VT40 | |
| AVSVLAAQKTGTPTV | 936 | Q8TCU4 | |
| RSVGSVPKVSAISKT | 6 | Q69YQ0 | |
| ATIPVSQISTIAGSK | 426 | Q53GS7 | |
| IKTVTLVLVVSSGLS | 206 | P51793 | |
| VLTTKVGSPATVTFQ | 2091 | Q12830 | |
| RLLGIKTETPSTVST | 1051 | Q9NRL2 | |
| AKGTEVIIITTDTSP | 136 | Q69YU3 | |
| VISVIGSTETTGKIV | 476 | Q9HBD1 | |
| IVISEKGASSPLITV | 816 | P69849 | |
| VSEGSIVSSSRKPIS | 506 | Q8IZ41 | |
| TGVGVVKVISTIPAT | 321 | Q8TD20 | |
| ITITVTDFGTPRLKT | 421 | Q9Y5E7 | |
| ITITVTDLGTPRLKT | 366 | Q96TA0 | |
| VIISIPLTETNKTSG | 1166 | O60271 | |
| ASFSKAIPTGTVLIT | 826 | Q9HCM3 | |
| VITPQILATLATGKT | 76 | Q8NGQ6 | |
| AVTPGTTTLPATVKV | 581 | P51610 | |
| GVTKTITLVKSPISV | 656 | P51610 | |
| LVTPVTVSAVKPAVT | 856 | P51610 | |
| KPAVTTLVVKGTTGV | 866 | P51610 | |
| GATLSPKTSTGAIVV | 36 | Q8WXI7 | |
| GVVTPLVTSSRAVIS | 10876 | Q8WXI7 | |
| PGVVTSLVTSSRAVT | 10931 | Q8WXI7 | |
| GVVTPLVTSSRAVTS | 11096 | Q8WXI7 | |
| AAGPLSTTVSVTITV | 1936 | Q96JQ0 | |
| SIISRTAKVAVAGPL | 126 | P43146 | |
| RSLSPIIGKDVLTST | 781 | Q9H4G0 | |
| IVISEKGASSPLITV | 816 | Q5JPE7 | |
| TILTNPVIAKVGTAT | 136 | Q8NGI2 | |
| PSKTITISESGVIGS | 281 | Q6MZP7 | |
| VAPASVITIVKSTPG | 131 | Q9ULX9 | |
| VPGKVAATSVITIVK | 141 | O15525 | |
| VIKAPVTGALITASS | 406 | Q14774 | |
| PVSTTVVSTSQAGKL | 1166 | Q6P4R8 | |
| VVSTSQAGKLPTRIT | 1171 | Q6P4R8 | |
| GSSKAVSTVVVTTAP | 1276 | Q6P4R8 | |
| VVSSRKLVGFISAIP | 216 | P30419 | |
| VPEFTKIQTLTSSVR | 51 | P16435 | |
| LETKVTVTSSPIRGA | 6 | Q9H2G9 | |
| ATVNLTKTTGITTPV | 1656 | Q8IWI9 | |
| TKTTGITTPVASVAF | 1661 | Q8IWI9 | |
| VVPKSVTLGTVVGSS | 166 | Q96EF0 | |
| GVISISKSTERLSPL | 921 | Q96NW7 | |
| SSEVGPFVSKIRAVI | 151 | Q13825 | |
| ISVTKPVVLASGAAL | 276 | Q9HC44 | |
| KITGNVVITLPTSTA | 696 | Q8IZA0 | |
| VSGALRATTPSVTVK | 166 | Q76N89 | |
| ESPAKSSVLVVGIVI | 291 | P55899 | |
| TVLTLPRVTKIGVAA | 136 | Q8TCB6 | |
| KIKLVGTTTTAPESR | 7121 | Q7Z5P9 | |
| KTGTTGVALSTTVAP | 7836 | Q7Z5P9 | |
| KIVTTGITTGTTIVP | 7976 | Q7Z5P9 | |
| IAKTVLISLPESGAT | 726 | Q96JB1 | |
| ILVLGFRKEPSSVTT | 861 | Q8TET4 | |
| TTSTSATVKVQGVPA | 2556 | O60229 | |
| IVISEKGASSPLITV | 816 | Q15155 | |
| PRGTTVSVKQLFSTL | 46 | A8MQ11 | |
| LVAPSVVVKGTLSVT | 2086 | P50851 | |
| KESVPARTVFGITTV | 266 | Q16445 | |
| IKTESAPARTSLGIT | 301 | P78334 | |
| VTLAIITVTPKSFGS | 346 | P18627 | |
| VATPVTTGQVKAVTS | 1066 | Q9NQV6 | |
| PTSVTATKGSLVGLV | 811 | Q5MIZ7 | |
| ATRVTAKIVTLVPAG | 251 | Q02509 | |
| TPRSTVGVAVLSGKL | 596 | Q96PQ7 | |
| RSSFSKVPGTVSSLV | 66 | Q8TAX0 | |
| VRPIIASISSGVVSI | 306 | Q15291 | |
| AVTVSGLVTVSLLKP | 181 | Q9Y2X0 | |
| SSILTPSVVIKLGTI | 136 | Q8NGF1 | |
| TGGTTVLATEKPTVI | 621 | O14786 | |
| VIGAKVDSTVKTVSP | 586 | Q9BWT3 | |
| TLVLPKSAFTVGLTV | 196 | P0C862 | |
| LIRKTSGTPTESTVA | 116 | Q9NRJ2 | |
| SGTTTPTVEEKLVVL | 151 | Q05DH4 | |
| SSAIIPVSGITVVKA | 146 | Q6ISB3 | |
| NLITVTVKESPTSVG | 511 | Q14781 | |
| ILLDTGTTPVTRKAA | 11 | O14981 | |
| KTPTKRSTLIISGVS | 526 | O14523 | |
| RSTLIISGVSKVPIA | 531 | O14523 | |
| VPFTTRTLDKATVLG | 391 | Q07973 | |
| KDAVPARTSLGITTV | 296 | Q8N1C3 | |
| GIKAVPSSASSVVVS | 1196 | Q8TD84 | |
| KIVTSLSLDAPVTGT | 1156 | Q5SYB0 | |
| IITVLKSVPFTARTA | 996 | Q8IVF7 | |
| TLPVGIRTVAVTKSQ | 321 | P08236 | |
| TGIVGTTVSRTKPAL | 146 | A2RUQ5 | |
| TLVLPKSAFTVGLTV | 196 | B2RNN3 | |
| TTKIKPRIVGGTASV | 381 | P03951 | |
| ISALFVTPKTTGARV | 286 | P09543 | |
| TGSLIVKERTVITVP | 491 | Q9UQ52 | |
| PAITKTTSVLQDGVI | 856 | Q9P267 | |
| QASGLKVPTTITLTL | 851 | Q9P2N6 | |
| IPKGTTIITSLTSVL | 381 | P33260 | |
| AAVTKLVPTSVIAST | 301 | Q7Z589 | |
| SGSIITVVPKSLATL | 536 | Q7Z589 | |
| LSAVPKQVVTGTVLT | 1036 | Q8WYP5 | |
| GVGRSTVTTKVTLPA | 221 | Q9Y4K1 | |
| QATILPKTGTVSLEV | 921 | P49327 | |
| FAISVVVKPSSTRGG | 91 | P39059 | |
| IPTGTILAIVTTSFI | 451 | Q9Y666 | |
| KATSVTVKGLVPARS | 646 | Q58EX2 | |
| GVERKPLVASTTALS | 471 | Q9Y467 | |
| AATTKPIVRSVSVVT | 36 | Q9UPN4 | |
| PIVRSVSVVTGSEQK | 41 | Q9UPN4 | |
| VTGKEPTRRFSTIVV | 106 | Q9BXL7 | |
| LAGSIPATKVEITVS | 16 | Q9HCH3 | |
| VTKVSTFILVGLPTA | 6 | Q6IFH4 | |
| QKSIPTGTILAIATT | 451 | Q9H2X9 | |
| SIFTVLTAKSVRPGV | 296 | Q93099 | |
| SVVPRKSTTGKVAIL | 1911 | Q6ZRI0 | |
| SSTRSKAPSVIITGL | 491 | Q9UF33 | |
| RVTFLPTGITFKSVT | 86 | Q9Y624 | |
| AKITPRSVLTTGIGS | 366 | Q9NXL9 | |
| SSGTLSVVAGIKPTR | 101 | Q96HJ5 | |
| VVEASTQLGPSTKVL | 1071 | Q8N2Y8 | |
| SEKSIIVSGATAPRT | 376 | Q92750 | |
| SFVGVVKSIATITVG | 256 | Q5M8T2 | |
| SAVAATKSPIIFIGT | 261 | P61011 | |
| PTKFTVSVSGICISV | 141 | Q96RI8 | |
| PTKFTVSVSGICIVL | 141 | Q96RI9 | |
| PTTVFKITVGRATTE | 451 | Q8N5C8 | |
| SIVVTQPRKIGASSI | 181 | Q8NDG6 | |
| SGRISSKETAPGLVV | 561 | Q9UPU3 | |
| IIRVTTVPGKTGTVA | 161 | P21462 | |
| VKSKVTVDTGVIPAS | 281 | O60841 | |
| VSIASFVTVKRPGVT | 296 | Q7Z3K3 | |
| IAPVVVAKGTLSITT | 2161 | Q8NFP9 | |
| EGSITRGTPTSKISV | 1141 | O75376 | |
| SKISVESIPSLRGSI | 1151 | O75376 | |
| PIFISGTIVDKSGRT | 221 | Q99707 | |
| VIISTSRVSAPAGGK | 691 | Q9NPR2 | |
| GSKVPLATVTVIDQS | 466 | Q86V20 | |
| STRTRQKGVTTAVIP | 211 | Q9NSC7 | |
| AATTLKGTAIPVRSV | 36 | Q9BZQ2 | |
| TTIIEGRITATPKES | 46 | Q9NVS2 | |
| VTVAVTSSPNAILGK | 101 | P49221 | |
| GTTAVLTQTVKPLTL | 246 | P40306 | |
| VASLKPGTQVIVLST | 646 | Q8WU76 | |
| KGLSARIISATPSTI | 276 | Q96H78 | |
| RIISATPSTIVIVVG | 281 | Q96H78 | |
| STALVVSTGAVKLPS | 491 | Q7Z745 | |
| VPTATRVAIVTFSSK | 116 | Q4LDE5 | |
| ITAGKLVTLPDITSV | 211 | Q96GA7 | |
| TTVAKTVTVTRPTGV | 1046 | A5YKK6 | |
| TVTVTRPTGVSFKKD | 1051 | A5YKK6 | |
| ITTITPGAFTTLVSL | 641 | O75094 | |
| IAGKIIPAIATTTAT | 886 | A0AVT1 | |
| RTKTPIIATLASGAV | 381 | P30825 | |
| KVAVLIREGVSSTTP | 836 | Q9H7N4 | |
| KLSTFLGVVVPTVLS | 36 | Q9BXP2 | |
| KGVTTSRTATITVLP | 211 | P30530 | |
| IAGKIIPAIATTTAA | 886 | P22314 | |
| FTVPATTVKIVSLGG | 601 | Q9H869 | |
| ETKVTSTVPLVGRSG | 231 | O43379 | |
| VVSKPVTVSRPIAIS | 301 | Q96KM6 | |
| ISGVTKAISSPTVSR | 151 | O94811 | |
| IKTVAGSGIARTIPS | 171 | Q86T82 | |
| RITGAPAVIFTKVVS | 1696 | Q7Z7G8 | |
| VEINPGLLVTVKTTS | 176 | Q9P0Z9 | |
| SEFTKIITPAITRVV | 216 | P10827 | |
| SVPESTVLKKVSGVL | 326 | P57081 | |
| LTVKVSASTRIGLLP | 316 | P11465 | |
| SLVSLGVSVSKPDVI | 41 | Q96ND8 | |
| VGVSQVTTLKPALST | 66 | P17021 | |
| AVPTVTAKIIGDAST | 911 | Q5VZL5 | |
| SESAIVPKTVKSGVV | 2436 | Q5THJ4 | |
| TTAPRTVKELTVSAG | 326 | Q5VV43 | |
| ITEVTKRPLTAGTLF | 566 | B0I1T2 |